1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
Repligen Corp.
XNAS: RGEN
Turnaround Potential
178.21 5.30 (3.07%)
76.46% Gain from 52W Low
583.7K
XNAS Volume

XNAS 17 Sep, 2026 2:46 PM (EDT)

Watchlist

Portfolio

Alert

Detailed Stock Analysis for Repligen Corp with Real-time Stock Report

Download Sample Report
crown icon
Premium Feature
Please subscribe to Pro or ProPlus
Subscribe Sign in